A BEACON OF HOPE AND HEALING TOUCH- Dr.BINDU LINGAM
Dr. Hima Bindu Lingam is a Medical Oncologist and Hematologist who works in both patient care and clinical research at Kaiser Permanente Townpark in Kennesaw…
The First Indian Mutation of NADH-Cytochrome b5 Reductase as a Cause for Type 1 Methemoglobinemia.
Congenital methemoglobinemia caused by cytochrome b5 reductase(b5R) deficiency is sporadic worldwide, although clusters of this disorder have been identified in certain ethnic groups…
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
The US Food and Drug Administration (FDA) approved elacestrant for the treatment of postmenopausal women or adult men with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2–), estrogen receptor 1 (ESR1)–mutated advanced or metastatic breast cancer with disease progression after at least one line of endocrine therapy (ET)..…